KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Assets (2016 - 2025)

Arbutus Biopharma's Return on Assets history spans 12 years, with the latest figure at 0.42% for Q3 2025.

  • For Q3 2025, Return on Assets rose 9.0% year-over-year to 0.42%; the TTM value through Sep 2025 reached 0.42%, up 9.0%, while the annual FY2024 figure was 0.51%, 8.0% down from the prior year.
  • Return on Assets for Q3 2025 was 0.42% at Arbutus Biopharma, up from 0.49% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.33% in Q3 2022 and bottomed at 0.62% in Q1 2025.
  • The 5-year median for Return on Assets is 0.48% (2023), against an average of 0.46%.
  • The largest annual shift saw Return on Assets skyrocketed 104bps in 2021 before it fell -14bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.51% in 2021, then soared by 32bps to 0.35% in 2022, then crashed by -38bps to 0.48% in 2023, then decreased by -7bps to 0.51% in 2024, then increased by 18bps to 0.42% in 2025.
  • Per Business Quant, the three most recent readings for ABUS's Return on Assets are 0.42% (Q3 2025), 0.49% (Q2 2025), and 0.62% (Q1 2025).